REPORT HIGHLIGHTS

The U.S. eldercare market reached $381.6 billion in 2014 and nearly $417 billion in 2015. The market should reach $512.7 billion in 2020, demonstrating a compound annual growth rate (CAGR) of 4.2% from 2015 to 2020.

This report provides:

An overview of the global markets for eldercare products and services.

Analyses of market trends, with data from 2014, estimates for 2015, and projections of CAGRs through 2020.

Segmentations of the market into healthcare products and services, housing services and needs, and assistive technologies.

Breakdowns of the U.S. and worldwide markets by demographics.

A focus on applications including:

Heart disease/stroke.

Cancer treatments.

Kidney disease medications.

Diabetes medications.

Arthritis prescription medications.

Osteoporosis medications.

Pain medications.

Neurological health medications (e.g., dementia, depression).

Respiratory medications and products.

Information covering the industry's structure.

Profiles of major players in the industry.

SCOPE OF REPORT

This report offers forecasts by product segment (i.e., healthcare, housing, and assistive devices and technology) from 2015 through 2020, including supporting analyses for projections.

Report segments include a demographic background of the market in the U.S. and worldwide, healthcare products and services, housing services and needs, and assistive technologies for the elder care market. International markets are discussed and information is provided on industry structure.

Profiles of leading companies involved in the elder care pharmaceutical, housing and assistive device industries are provided. Information on company placement within the designated market and strategic analyses of the companies' available and emerging products are discussed.

ANALYST'S CREDENTIALS

Peggy S. Lehr is the market research analyst of this report. Ms. Lehr holds a BS in Journalism from the University of Colorado, Boulder, and a MS in Communication from the University of Denver. Ms. Lehr has been involved with the medical/nursing industry for more than 25 years.

Table of Contents

Product Code: HLC062C

Table of Contents

CHAPTER 1 - INTRODUCTION

STUDY GOALS AND OBJECTIVES

REASONS FOR DOING THE STUDY

SCOPE OF REPORT

INTENDED AUDIENCE

INFORMATION SOURCES

ANALYST'S CREDENTIALS

RELATED BCC RESEARCH REPORTS

BCC RESEARCH WEBSITE

DISCLAIMER

CHAPTER 2 - SUMMARY

EMPHASIS OF THE REPORT

HEALTHCARE

HOUSING

ASSISTIVE TECHNOLOGY

SUMMARY TABLE: U.S. MARKET FOR INDIVIDUALS OVER 65 BY TYPE OF NEED, THROUGH 2020 ($ MILLIONS)

SUMMARY FIGURE: U.S. MARKET FOR INDIVIDUALS OVER 65 BY TYPE OF NEED, 2015 AND 2020 (%)

CHAPTER 3 - OVERVIEW OF GLOBAL ELDERLY POPULATION

DEFINITIONS

TRENDS IN GLOBAL AGING

HEALTHCARE AND AGING

Volunteer Care

In-home Care

Hospice Care

THE GLOBAL ENVIRONMENT FOR THE ELDERLY

GLOBAL SOCIAL ENVIRONMENT

Intergenerational Living Issues in Developing Countries

Intergenerational Living Issues in Developed Countries

GLOBAL HOUSING REALITY FOR THE ELDERLY

Europe

China

GLOBAL ECONOMIC REALITY FOR THE ELDERLY

Economic Trends for Elderly Outside the U.S.

Europe

India

Japan

Economic Trends for U.S. Elderly

GLOBAL DEMOGRAPHIC TRENDS, BY COUNTRY

TABLE 1: PERCENT OF POPULATION AGE 65 AND OLDER IN SELECTED COUNTRIES, 2014 (MILLIONS/%)

THE ELDERLY IN THE U.S.

DEMOGRAPHICS IN THE U.S.

TABLE 2: ESTIMATED ELDERLY POPULATIONS COMPARED WITH OVERALL POPULATIONS, WITH PERCENT OF POPULATION BY U.S. STATE, 2014 (POPULATION/%)

HEALTH OF THE U.S. ELDERLY

U.S. Health Trends

Discrepancies in Minority Health Status

Elderly Living with Chronic Health Conditions

SHIFTING DEMOGRAPHICS IN THE U.S.

Racial and Ethnic Changes

GOVERNMENT LEGISLATION AND PROGRAMS AIMED AT THE ELDERLY

AMERICANS WITH DISABILITIES ACT

ADA and Employee Rights

TELECOMMUNICATIONS ACT OF 1934

FAIR HOUSING ACT

AIR CARRIER ACCESS ACT

VOTING ACCESSIBILITY FOR THE ELDERLY AND HANDICAPPED ACT OF 1984

ARCHITECTURAL BARRIERS ACT OF 1968

MEDICAL DEVICE LEGISLATION

AMERICAN RECOVERY AND REINVESTMENT ACT OF 2009

AFFORDABLE CARE ACT

U.S. GOVERNMENT-SPONSORED AND PRIVATELY SPONSORED NUTRITION PROGRAMS

END-OF-LIFE CONSIDERATIONS

LEGAL MATTERS

HOSPICE CARE

INTERNMENT ISSUES

CHAPTER 4 - INDUSTRY TRENDS BY SECTOR - HEALTHCARE

U.S. HEALTHCARE FOR INDIVIDUALS OVER 65

TABLE 3: U.S. MARKET FOR HEALTHCARE MEDICATIONS, PRODUCTS AND SURGICAL PROCEDURES FOR INDIVIDUALS OVER 65 BY CONDITION, THROUGH 2020 ($ MILLIONS/%)

ARTHRITIS

CURRENT TREATMENTS

Medications

Rheumatoid Arthritis

COX2 Inhibitors

Disease-modifying Antirheumatic Drugs

Biologics

Corticosteroids

NSAIDs

Osteoarthritis

THE FUTURE BURDEN OF ARTHRITIS IN THE U.S.

FIGURE 1: FUTURE BURDEN OF ARTHRITIS FOR INDIVIDUALS OVER 65 IN THE U.S. BY GENDER, 2010-2030 ($ MILLIONS)

ARTHRITIS TREATMENT MARKET PROJECTIONS

TABLE 4: U.S. MARKET FOR PRESCRIPTION ARTHRITIS MEDICATIONS FOR INDIVIDUALS OVER 65, THROUGH 2020 ($ MILLIONS)

CARDIOVASCULAR DISEASES

CARDIOVASCULAR DISEASE IN THE U.S.

Risk Factors

Current Treatments for Heart Disease

Surgical Options

Heart Disease Medications

TABLE 5: SELECTED LISTING OF HEART DISEASE MEDICATIONS BY BRAND NAME AND MANUFACTURER